![Gerry Hanna: Chinese study in patients with EGFR positive oligo-organ metastatic NSCLC](https://oncodaily.com/pub/uploads/2025/02/Gerry-Hanna-1280x720.jpg)
Gerry Hanna/X
Feb 8, 2025, 13:48
Gerry Hanna: Chinese study in patients with EGFR positive oligo-organ metastatic NSCLC
Gerry Hanna, Marie Curie Chair of Clinical Oncology at Trinity College Dublin, shared a post on X about a paper by Hongfu Sun et al. published in the Journal of Clinical Oncology:
“Interesting paper just out in Journal of Clinical Oncology.
Chinese study in patients with EGFR positive oligo-organ metastatic NSCLC. TKI plus RT group received 60Gy to primary and positive LNs. RT to metastases determined by clinicians.
Median OS was 26.2 months and 34.4 months (RT).”
Authors: Hongfu Sun et al.
More posts featuring Gerry Hanna.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 8, 2025, 13:24
Feb 8, 2025, 12:46
Feb 8, 2025, 12:19
Feb 8, 2025, 12:17